Corcept Therapeutics (CORT) Net Income towards Common Stockholders (2010 - 2026)
Corcept Therapeutics (CORT) posted Net Income towards Common Stockholders of $42.14 million for Q2 2026, up 21.8% from $34.61 million a year earlier.
Powered by 
Analysis
Corcept Therapeutics (CORT) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Corcept Therapeutics was $54.2 million, down 58.9% year-over-year; for FY2025, it came in at $98.17 million, down 29.7% from FY2024.
- Annual Net Income towards Common Stockholders shows a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- In prior years, Corcept Therapeutics' Net Income towards Common Stockholders was $139.73 million in FY2024 (+32.5%), $105.5 million in FY2023 (+4.2%), $101.29 million in FY2022 (-10.0%) and $112.51 million in FY2021 (+6.1%).
- The Q2 2026 figure stands as the highest quarterly Net Income towards Common Stockholders since Q3 2024.
- On a year-over-year basis, Net Income towards Common Stockholders increased in two of the last seven quarters, with an average decline of 5.5%.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was Q4 2023, with growth of 88.4%; the weakest was Q3 2025, with a decline of 58.5%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was -$31.2 million (Q1 2026), $23.9 million (Q4 2025) and $19.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Corcept Therapeutics | 12.56 Bn | 11.12 Bn | 252.09 Mn | 42.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.14 Mn |
| Mar 31, 2026 | -31.20 Mn |
| Dec 31, 2025 | 23.90 Mn |
| Sep 30, 2025 | 19.36 Mn |
| Jun 30, 2025 | 34.61 Mn |
| Mar 31, 2025 | 20.29 Mn |
| Dec 31, 2024 | 30.39 Mn |
| Sep 30, 2024 | 46.69 Mn |
| Jun 30, 2024 | 35.12 Mn |
| Mar 31, 2024 | 27.51 Mn |
| Dec 31, 2023 | 31.14 Mn |
| Sep 30, 2023 | 31.17 Mn |
| Jun 30, 2023 | 27.36 Mn |
| Mar 31, 2023 | 15.81 Mn |
| Dec 31, 2022 | 16.53 Mn |
| Sep 30, 2022 | 34.55 Mn |
| Jun 30, 2022 | 27.40 Mn |
| Mar 31, 2022 | 22.80 Mn |
| Dec 31, 2021 | 32.05 Mn |
| Sep 30, 2021 | 30.47 Mn |
API Access
Corcept Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();